micromobility.com Inc. (MCOM): Nasdaq/NYSE listing notice — Micromobility receives Nasdaq delisting notice for failure to maintain $35M market value of listed securities

micromobility.com Inc.

Received additional Nasdaq delisting notice on Oct 31, 2023 for failing to maintain $35M market value of listed securities for 30 consecutive days.
Company to submit views to Nasdaq hearings panel by Nov 7; panel may grant extension but no assurance.
No immediate effect on listing or trading; warrants (MCOMW) would be concurrently delisted if common stock delisted.
Company previously submitted compliance plan; monitoring options to regain compliance.

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

micromobility.com Inc. received a nasdaq delisting notice notice regarding market value (rules 5550(b)(1), 5810(c)(3)(C)).

Exchange: nasdaq
Notice: delisting notice
Deficiency: market value
Rules: 5550(b)(1), 5810(c)(3)(C)

Exact text from the filing

October 31, 2023, micromobility.com Inc. (the “Company”) received an additional written notice of determination of delisting (the “Notice”) from the Listing Qualifications Department of the Nasdaq Stock Market, LLC (“Nasdaq ”) notifying the Company that, based on the market value of the Company’s class A common stock, par value $0.00001 per share (the “Common Stock”), the Company did not comply with the market value of listed securities requirement for continued listing on the Nasdaq Capital Market pursuant to Nasdaq Listing Rule 5550(b)(1) (the “Rule”). The Rule requires listed securities to

View on SEC.gov

Browse all listing & compliance notices →

micromobility.com Inc. filing history →

Source: SEC EDGAR

accession 0001079973-23-001531

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.